| (Values in U.S. Thousands) | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2018 | Dec, 2017 |
| Sales | 194,750 | 123,800 | 2,110 | 0 | 0 |
| Sales Growth | +57.31% | +5,767.30% | unch | unch | unch |
| Net Income | -303,090 | -247,550 | -266,770 | -174,190 | -117,020 |
| Net Income Growth | -22.44% | +7.20% | -53.15% | -48.85% | -41.89% |
Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops treatments for underserved patient communities.
Fiscal Year End Date: 12/31